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Abstract.  15 
Commensal butyrate-producing bacteria in the Firmicutes phylum are abundant in the 16 
human intestine and are important for maintaining health. However, understanding of the 17 
metabolism and host interaction of these bacteria is limited by the lack of genetic modification 18 
techniques. Here we establish a protocol enabling the transfer of autonomously-replicating 19 
shuttle vectors by conjugative plasmid transfer from an Escherichia coli donor into 20 
representatives of an important sub-group of strictly anaerobic human colonic Firmicutes. Five 21 
different plasmid shuttle vectors were tested, each carrying a different origin of replication 22 
from Gram-positive bacteria. Plasmid pMTL83151 (pCB102 replicon) were successfully 23 
transferred into two strains of Eubacterium rectale, while pMTL83151 and pMTL82151 (pBP1 24 
replicon) were transferred into Roseburia inulinivorans A2-194. Plasmids that carried a 25 
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Streptococcus bovis JB1 glycoside hydrolase family 16 -(1,3-1,4)-glucanase gene were 26 
constructed and conjugated into Roseburia inulinivorans A2-194 and Eubacterium rectale T1-27 
815, resulting in successful heterologous expression of this introduced enzymatic activity in 28 
these two strains of butyrate-producing Firmicutes.  29 
 30 
Introduction  31 
 32 
The human intestinal microbiota produces short chain fatty acids (SCFA) as end 33 
products of anaerobic fermentation. These SCFA are involved in a wide variety of health 34 
promoting functions. It has been suggested that intestinal bacteria that produce butyrate as their 35 
main fermentation end product have potential as novel, health-promoting probiotics [1, 2]. This 36 
prediction seems reasonable, considering several observations. Firstly, butyrate reinforces the 37 
colonic defence barrier by stimulating tight junction formation [3], antimicrobial secretion [4], 38 
and mucin synthesis [5]. Secondly, butyrate regulates macrophage and dendritic cell 39 
differentiation, maturation and function in a manner that promotes tolerance to the intestinal 40 
microbiota [6, 7]. These properties make butyrate, or butyrate-producing bacteria, of potential 41 
interest for treatment of conditions such as ulcerative colitis (UC) and Crohn’s disease, which 42 
are characterised by colonic barrier damage and inflammation [8]. 43 
Species of the genera Roseburia, Eubacterium and Faecalibacterium are the most 44 
abundant butyrate producing bacteria in the human colonic microbiota [9]. Genome sequences 45 
of multiple members of these genera are now available, but the lack of genetic modification 46 
techniques has limited our ability to determine the functions of specific genes.  47 
Heterologous gene expression systems have been extensively used in molecular 48 
microbiology to determine the impact of environmental stimuli on individual steps within 49 
biochemical pathways and also for the expression of a variety of proteins of commercial and 50 
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biomedical interest [10]. Although several well studied bacterial and in vitro (or cell-free) 51 
expression systems are available, these are often insufficient for expression and 52 
characterisation of specific proteins [11, 12]. Furthermore, the expression of certain proteins 53 
can be toxic in some bacterial hosts, while use of the wrong expression host can result in low 54 
or no expression, and/or unfolded or misfolded proteins [13]. It would therefore be 55 
advantageous to create expression vectors for key members of the human gut microbiota, to 56 
facilitate investigating the function of the vast array of candidate host interaction factors and 57 
metabolic enzymes in these bacteria that have been uncovered by recent microbiome studies 58 
[14].  59 
In previous work, the conjugative transposons Tn1545 from Eubacterium 60 
cellulosolvens and TnK10 from Clostridium saccharolyticum K10 were transferred into R. 61 
inulinivorans A2-194 [15], demonstrating conjugation as a means of introducing exogenous 62 
DNA into these species. However, in order to be maintained in the progeny of a recipient, a 63 
transposon must both transfer into the recipient strain and insert into the recipient chromosome. 64 
Both of these steps are low frequency occurrences whose combined probability is the 65 
conjugation frequency multiplied by the frequency of chromosomal insertion. The ability of 66 
autonomously-replicating plasmid vectors to stably replicate in the recipient greatly mitigates 67 
this “bottlenecking effect”. 68 
Although no autonomously replicating plasmids have yet been isolated from any 69 
member of Roseburia/E. rectale group, a series of modular plasmids have recently been 70 
developed for members of the Clostridium genus. These shuttle plasmids/vectors are each 71 
composed of four modular sections, with several variations available and can replicate 72 
autonomously in a range of clostridial species [16]. Since they replicate in E. coli, they can be 73 
readily isolated and manipulated, and are then transferable via E. coli-Clostridium mating.  74 
  75 
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Our aim here was to establish protocols by which a shuttle vector could be transferred 76 
by conjugation from a donor strain into the bacterium of interest, leading to stable plasmid 77 
maintenance. Firstly, relevant indigenous antibiotic resistance genes and restriction 78 
modification systems (RMS) were identified in candidate butyrate-producing bacteria, using 79 
both in silico and in vitro methods. Protocols for the conjugative transfer of an autonomously-80 
replicating plasmid vector into strains of biological interest were then established. Optimisation 81 
of the protocols permitted conjugative transfer of plasmid vectors into Roseburia inulinivorans 82 
A2-194 and Eubacterium rectale T1-815 and enabled the heterologous expression of a β-(1,3-83 
1,4)-glucanase gene from Streptococcus bovis JB1 in these dominant butyrate-producing 84 
bacteria. The β-(1,3-1,4)-glucanase gene was chosen as this readily demonstrable enzymatic 85 
activity is not naturally found in the target bacteria.  86 
 87 
Materials and methods 88 
Bacterial strains, plasmids, primers and growth conditions 89 
The strains and plasmids used in this study are described in Table 1. All primers used 90 
in this study are listed in Table S1. Anaerobic strains were cultured in the anaerobic media 91 
M2GSC [17], YCFAGSC [18] or AMM (anaerobic mating medium, this work). AMM 92 
consisted of (per 100 ml) Casitone (1.0 g), yeast extract (0.25 g), NaHCO3 (0.4 g), cysteine 93 
(0.1 g), K2HPO4 (0.045 g), KH2PO4 (0.045 g), NaCl (0.09 g), (NH4)2SO4 (0.09 g), MgSO4 94 
7H2O (0.009 g), CaCl2 (0.009 g), resazurin (0.1 mg), hemin (1 mg), biotin (1 μg), cobalamin 95 
(1 μg), p-aminobenzoic acid (3 μg), folic acid (5 μg), pyridoxamine (15 μg) and acetate (5 96 
mM). Broths of these media were divided into 7.5 ml aliquots in Hungate tubes, sealed with 97 
butyl rubber septa (Bellco Glass) and agars (with the addition of 2% agar) were divided into 98 
100ml aliquots in Wheaton bottles, with all dispensing carried out under anaerobic conditions 99 
using 100% CO2. Roseburia species, E. rectale and Faecalibacterium prausnitzii cultures were 100 
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inoculated using the anaerobic methods described by Bryant, 1972 [19] and incubated 101 
anaerobically without agitation at 37 °C. Agar plate work was carried out in Concept Plus 102 
Anaerobic Workstation, Ruskinn Technology with a gas mix of CO2: N2: H2, in a ratio of 7:11:2 103 
respectively. Escherichia coli strains were cultured aerobically in L-broth and on L-agar at 37 104 
°C, including, where appropriate, 10 μg/ml chloramphenicol. 105 
 106 
In silico analysis of restriction modification systems (RMS) 107 
Bioinformatic annotation of the RMS of selected species required the merging of lists 108 
of putative restriction-associated proteins from two databases: NCBI and REBASE 109 
(http://www.ncbi.nlm.nih.gov and http://rebase.neb.com/rebase/rebase.ftp.html). The physical 110 
locations of the sequences encoding the putative proteins in the genomes of R. intestinalis L1-111 
82, R. inulinivorans A2-194, E. rectale A1-86 and F. prausnitzii A2-165 were determined and 112 
these genomic regions were subject to manual curation in Artemis [20]. The most likely 113 
candidates for RMS were then determined based on co-localisation of predicted restriction 114 
endonucleases and methylase encoding genes 115 
 116 
Preparation of protein extracts for restriction analysis 117 
Cultures of selected butyrate-producing strains were grown in 7.5 ml of M2GSC broth 118 
for 48 h at 37 °C. These cultures were transferred to 15 ml plastic tubes and centrifuged (6000 119 
g, 10 min, 4 °C). The supernatants were decanted and the pellets were resuspended in 5 ml 120 
Sonication Buffer (Tris-HCl (0.315 g), β-mercaptoethanol (0.195 ml) and distilled water (up 121 
to 100 ml), pH 8). The solutions were then sonicated with the Sanyo, Soniprep 150 in six 30 122 
sec bursts (22µm amplitude) – cooling for 30 sec on ice between bursts. Streptomycin sulphate 123 
was added to the solutions to a final concentration of 2% as a means of removing nucleic acids. 124 
These solutions were incubated on ice for 30 min and centrifuged (11,000 g, 10 min, 4 °C). 125 
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The resulting supernatants were transferred to new 15 ml tubes and polyethylene glycol (PEG) 126 
6000 was added to a final concentration of 10%. These mixes were incubated on ice for 30 min 127 
and centrifuged (11,000 g, 10 min, 4 °C). The resulting pellets were resuspended in 1 ml of 128 
phosphate buffer solution (pH 7) and transferred to 1.5 ml tubes, and PEG 6000 was again 129 
added to a final concentration of 10% and incubated on ice for 30 min. These were centrifuged 130 
(11,000 g, 10 min, 4 °C) and the final pellets were resuspended in 30 μl of phosphate buffer 131 
solution. These protein extracts were frozen at -20 °C. All steps after culturing were performed 132 
on ice when possible. 133 
During restriction analysis, protein extracts (2 μl) were incubated with purified plasmid 134 
DNA (200 ng) in 15 μl of water and NEBuffer 3.1 (NEB) for 90 min at 37 °C prior to separation 135 
by agarose gel electrophoresis. This buffer (NEBuffer 3.1 ) was chosen because in prior tests 136 
it facilitated lambda DNA degradation in a similar efficient way with each of the protein 137 
extracts. 138 
 139 
Development of selective plating conditions for mating experiments 140 
Bacterial strains were tested for resistance to the antibiotics chloramphenicol, thiamphenicol 141 
(an analogue of chloramphenicol), erythromycin, tetracycline and rifampicin. Bacteria were 142 
spread on YCFAGSC agar plates supplemented with different concentrations of each antibiotic 143 
(5, 10 and 25 µg/ml) and growth monitored after 120 h of anaerobic incubation at 37 °C.  144 
Overnight cultures of all Roseburia and Eubacterium rectale strains listed in Table 1, and E. 145 
coli CA434 (donor strain) were streaked on duplicate, well-dried M2GSC and YCFAGSC agar 146 
plates and incubated either anaerobically or aerobically for 48 h at 37 °C. Additional tests with 147 
YCFAGSC containing a reduced SCFA concentration (Table 3) were included. 148 
Conjugation protocol optimised for the Roseburia inulinivorans and Eubacterium rectale  149 
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The E. coli donor strain CA434 was first transformed with the relevant plasmid by 150 
electroporation using standard procedures [21]. The resulting transformant was grown 151 
overnight in 40 ml of LB supplemented with 10 μg/ml of chloramphenicol. The overnight 152 
culture was then centrifuged (1200 g, 10 min, 20 °C), the supernatant decanted and the pellet 153 
gently resuspended in 20 ml of phosphate-buffered saline (PBS, pH 7.4). These washed cells 154 
were again centrifuged (1200 g, 10 min, 20 °C) and transferred into the anaerobic workstation. 155 
The supernatant was decanted and the pellet was gently resuspended in 1 ml of an overnight 156 
culture of the recipient strain, grown in M2GSC. 100 μl of this mix was then dotted onto an 157 
agar plate of AMM or M2GSC and incubated anaerobically for 48 h. The resulting bacterial 158 
growth was scraped off the plate and resuspended in 500 μl of anaerobic-PBS (reduced by 159 
boiling, followed by addition of L-cysteine and bubbling with CO2 gas). 50 μl of this cell 160 
suspension was spread onto YCFAGSC agar plates. The high short-chain fatty concentration 161 
present in YCFAGCS prohibits the growth of E. coli (this work and [22]), and the addition of 162 
chloramphenicol (5 or 7.5 μg/ml) selected for plasmid uptake by the recipients. Colonies that 163 
grew were purified as single colonies following streaking on fresh YCFAGSC plates 164 
supplemented with chloramphenicol. 165 
 166 
Verification of putative transconjugants 167 
Aerobic growth experiments involved streaking of putative transconjugants onto 168 
M2GSC agar plates and incubating aerobically at 37 °C for 48 h. Since the obligately anaerobic 169 
recipient strains cannot grow in the presence of oxygen, any aerobic growth was attributed to 170 
persistent E. coli cells. Stocks were made of all cultures able to grow anaerobically and not 171 
aerobically. The 16S rRNA gene was amplified directly from bacterial pellets by polymerase 172 
chain reaction (PCR) using primers FD1 and RP2 (Table S1). The resulting amplicon was then 173 
purified using the Wizard SV Gel and PCR Clean-Up System, following the manufacturer’s 174 
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instructions, and sequenced using 519R and 926F primers. Sequence quality was checked 175 
manually using Chromas Lite software, and the bacterial identity confirmed by BLASTn, 176 
querying each sequence against the NCBI 16S rRNA gene database. An alignment of the 177 
different sequences is shown (Fig. S1). The presence of the plasmid in putative transconjugants 178 
was confirmed by amplifying a nucleotide sequence common to all of the modular plasmids 179 
but absent in the recipient’s chromosome, using the primers PS#MTL-for and PS#MTL-rev 180 
(Table S1). Plasmids were shown to be autonomously-replicating in transconjugants by 181 
Southern blotting. Genomic DNA of putative transconjugants was digested with the restriction 182 
enzyme HindIII prior to Southern blotting. Southern blotting was performed with DIG High 183 
Primer DNA Labelling and Detection Starter Kit II (Roche Diagnostics), following the 184 
manufacturer’s instructions, using a probe that was specific to a region common to all of the 185 
plasmids, but not present in the recipient chromosome. 186 
Coomassie staining of the total protein complement involved centrifuging 7.5 ml 187 
overnight cultures (800 g, 10 min, 20 °C). The resulting pellets were resuspended in 2 ml of 50 188 
mM sodium phosphate buffer and centrifuged (800 g, 10 min, 20 °C). These pellets were 189 
resuspended in 200 μl of 50 mM sodium phosphate buffer. 6 μl of these solutions were added 190 
to each well of a 10% SDS-PAGE gel, and visualised by staining with Coomassie blue stain 191 
followed by destaining with “destain solution” (45.4% methanol, 9.2% acetic acid, 45.4% 192 
water).  193 
 194 
Plasmid stability determination 195 
Plasmid stability was determined by continuously subculturing transconjugants 196 
anaerobically in M2GSC broth lacking antibiotic, as described previously [23]. Briefly, 197 
overnight cultures of two transconjugants, isolated from independent conjugation experiments, 198 
were diluted to OD650 0.1 in fresh M2GCS broth (lacking antibiotic). The broths were incubated 199 
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for 12 h, and used either to inoculate a fresh broth to an OD650 0.1 or to create serial dilutions 200 
in reduced PBS (10-1 – 10-8). The inoculated fresh broth was incubated for 12 h and either re-201 
inoculated or a dilution series made This was repeated four times. At each stage, the PBS 202 
dilutions were plated (50 μl) onto YCFAGSC plates within 1 h of dilution and the plates were 203 
incubated for 48 h in the anaerobic workstation. Colonies that grew on these plates were picked 204 
in duplicate onto YCFAGSC plates with or without antibiotic. The proportion of bacteria still 205 
harbouring the plasmid was calculated by dividing the number of colonies that grew on the 206 
antibiotic plates by the cell numbers on the plates lacking antibiotic. All cultures steps were 207 
carried out anaerobically. 208 
Growth curves of strains in M2GSC broth lacking antibiotics were used to estimate the 209 
number of generation times the bacteria had gone through in each 12 h growth period. 210 
Instability was calculated as percentage plasmid loss per generation in the absence of antibiotic 211 
selection, using the formula x = 1 – R1/N, where x = segregational instability, R = fraction of 212 
bacteria still possessing plasmid and N = number of generations.   213 
 214 
Construction of the pMTL3β-glu expression vector 215 
An amplicon containing the β-(1,3-1,4)-glucanase gene (with its native promotor) from 216 
pL1Hc (Ekinci et al. 1997) was generated using the primers PS#Bglu-BamHI-for and PS#Bglu-217 
HindIII-rev, which possess 5’-end restriction sites for BamHI and HindIII, respectively. The 218 
PCR was performed in a 50 μl of reaction mix: Bioline Taq Polymerase and buffer, with 2.5 219 
mM MgCl2 and 200 μM of each primer. The PCR involved a hot start (94 °C, 5 min), followed 220 
by 28 cycles of denaturation (95 °C, 30 s), annealing (52 °C, 30 s) and elongation (72 °C, 2 221 
min), and followed by a final elongation step (72 °C, 8 min). The product of this reaction was 222 
purified from a 1% agarose gel using the QIAquick Gel Extraction Kit, following 223 
manufacturer’s instructions. The amplicon and the plasmid pMTL83151 were double-digested 224 
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separately in 30 μl reactions containing Promega Buffer E and 10 ng each of Promega BamHI 225 
and HindIII restriction enzymes, incubated overnight at 37 °C. The double-digest of the 226 
plasmid was then dephosphorylated with calf intestinal alkaline phosphatase (CIAP) for 30 min 227 
at room temperature, to prevent self-ligation. Both digests were then cleaned using Wizard SV 228 
Gel and PCR Clean-Up System and the products were ligated with Promega T4 Ligase and 229 
buffer, incubating overnight at 4 °C. The ligation product was then transformed into XL1-Blue 230 
Competent Cells (Stratagene), following manufacturer’s instructions, and transformants 231 
selected based on chloramphenicol resistance. Cloning was confirmed by restriction analysis. 232 
The plasmids containing the insert, designated pMTL3β-glu, were purified using QIAprep Spin 233 
Miniprep Kit. 234 
 235 
Testing functional activity of a heterologously expressed protein  236 
The pMTL3β-glu expression vector was electroporated into E. coli donor strain CA434 237 
using standard procedures [21]. It was then transferred from E. coli CA434 into R. 238 
inulinivorans A2-194 and E. rectale T1-815 following the optimised conjugation protocol, 239 
described above. Transconjugants were streaked on to fresh M2GSC agar plates and incubated 240 
anaerobically at 37 °C for 24 h. An overlay solution was prepared anaerobically using 0.1 % 241 
Glucagel from PolyCell Technologies (Glucagel contains 78.2 % β-glucan) and 0.8 % agarose 242 
in 50mM sodium phosphate buffer (pH 7) and divided into 4 ml aliquots in Hungate tubes. 243 
These were then poured over the pre-grown transconjugant-containing agar plates and again 244 
incubated overnight anaerobically. Finally the plates were stained with Congo red (1 mg/ml) 245 
for 30 min. The Congo red was then decanted and the plates destained using 1M NaCl for 30 246 
min before observing on a light box to visualise clear zone formation. 247 
 248 
Quantitative enzymatic assay 249 
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 Overnight cultures (7 ml in YCFAGSC) were centrifuged (1200 g, 10 min, 4 °C) and 250 
the resulting pellets were washed twice in 3 ml PBS (pH7.4) and re-centrifuged, before 251 
resuspending in 400 µl of 50 mM sodium phosphate buffer (pH 6.5) containing 2mM 252 
dithiothreitol (DTT). They were then sonicated in an ice bath with 4 x 30 second bursts or 253 
until lysis was visible. Sonicated extracts (25 µl) were incubated aerobically for 2 h at 37 °C 254 
in 50 mM sodium phosphate buffer (pH 6.5) containing 2 mM DTT with 1% Glucagel as 255 
substrate and the protein concentration in each sample was measured using the method of 256 
Lowry. Enzyme activity was determined by measuring the release of reducing sugars [24], as 257 
described previously [25]. One unit of enzyme activity is equivalent to the release of 1 µmol 258 
glucose min-1 (mg protein)-1. 259 
  260 
Results 261 
 262 
Antibiotic resistance profiles of candidate recipient strains 263 
 All the potential recipient bacteria were susceptible tochloramphenicol, thiamphenicol 264 
and rifampicin at the tested concentrations. R. intestinalis L1-82 grew in the presence of 10 265 
µg/ml tetracycline and R. inulinivorans A2-194 was resistant to erythromycin (Table 2). 266 
Bioinformatic analysis of the R. inulinivorans A2-194 genome identified a putative macrolide-267 
specific ABC-type efflux carrier (GenBank: CRL37109.1) that may be responsible for the 268 
erythromycin resistance phenotype of the strain, and analysis of the R. intestinalis L1-82 269 
genome identified chromosomally adjacent putative tetO and tet(40) genes (WP_006858004 270 
and WP_044999308, respectively). The putative tet(40) product is 100 % identical to the 271 
experimentally validated tet(40) protein from Clostridium cf. saccharolyticum K10 272 
(CBK76340.1) [26], making it a likely contributor to tetracycline resistance in R. intestinalis 273 
L1-82. A rifampicin resistant R. inulinivorans A2-194 mutant strain (A2-194R) was obtained 274 
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by selecting for the generation of spontaneous mutations that conferred rifampicin resistance 275 
(this work).    276 
Chloramphenicol resistance was thus chosen as the preferred marker incorporated in 277 
the shuttle vector to select transconjugants as none of the wild type strains could grow on 278 
YCFAGSC supplemented with 5 µg/ml of this antibiotic (Table 2).  279 
 280 
Developing optimal selective conditions for mating experiments 281 
Different media were tested to distinguish the growth of the donor E. coli CA434, and 282 
recipient Roseburia and Eubacterium rectale strains. All of the strains grew to large (> 1 mm) 283 
colonies on anaerobic M2GSC incubated anaerobically, while only E. coli CA434 grew when 284 
incubated aerobically (Table 3). E. coli CA434 did not grow on YCFAGSC incubated 285 
anaerobically (even after 120 h), but could grow aerobically or if the SCFA concentration was 286 
reduced (Table 3). This is assumed to reflect inhibition of anaerobic E. coli growth by the 287 
SCFA present in the medium [22]. While M2GSC medium was suitable for matings between 288 
E. coli and the recipient strains, the rumen fluid component can be difficult for many labs to 289 
source and has batch-to-batch variations. Therefore, a defined mating medium, AMM, was 290 
designed in the course of this work (see Materials & Methods). Anaerobic YCFAGSC 291 
supplemented with chloramphenicol was used as the selective medium for transconjugants as 292 
it prevented growth of the E. coli donor strain and of the wild-type recipient strains, but 293 
permitted growth of chloramphenicol resistant transconjugants.  294 
 295 
Conjugative transfer of autonomously-replicating plasmid to E. rectale A1-86 296 
Plasmid screening of the strains listed in Table 1 did not reveal any small endogenous 297 
plasmids that might be developed as vectors, so we decided to consider existing Gram-positive 298 
vectors. The plasmid pMTL960 was initially chosen as candidate shuttle vector as it possesses 299 
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the origin of replication of the plasmid pCD6 from Clostridium difficile – a species belonging 300 
to the same order (Clostridiales) as the Roseburia genus. This plasmid can be conjugated from 301 
E. coli into a range of different Clostridium species and replicates autonomously within the 302 
recipient [23]. However, no transconjugants were obtained following matings between an E. 303 
coli donor harbouring pMTL960 and R. inulinivorans A2-194. In silico analysis of the genome 304 
sequences of R. inulinivorans A2-194 (ACFY01000000), R. intestinalis L1-82 305 
(ABYJ00000000.2), E. rectale A1-86 (NC_021010.1) and F. prausnitzii A2-165 306 
(NZ_ACOP00000000.2) revealed that they possessed a variety of predicted restriction 307 
modification systems (RMS) that may hinder the uptake of exogenous DNA (Table 4; Table 308 
S3). Therefore, an improved assay for in vitro restriction activity (based on [27] was established 309 
for the restriction analysis of E.coli-Clostridium plasmid shuttle vectors [16, 23]. Plasmids 310 
pMTL82151, pMTL83151, pMTL84151 and pMTL85151, which are identical to each other 311 
except for their Gram-positive origin of replication (Table 1), were incubated with protein 312 
extracts from representative putative recipients. The plasmids were apparently not restricted by 313 
E. rectale A1-86 (Fig. 1, lanes A), as the smallest visible band is the same size as that of the 314 
undigested plasmid. Faint unrestricted bands are also present for R. inulinivorans A2-194 315 
incubations with plasmids pMTL84151 and pMTL83151 while pMTL82151 appears to be 316 
more degraded (Fig. 1 lanes E). The remaining combinations of plasmids and bacterial protein 317 
extracts indicate restriction activity, evidenced by the appearance of specific smaller bands or 318 
the complete disappearance of distinct plasmid bands on the agarose gels. 319 
Following conjugation, chloramphenicol resistant transconjugants of E. rectale A1-86 320 
were obtained containing the pMTL83151 plasmid. These transconjugants (coded as follows: 321 
EAM3- E. rectale A1-86 harbouring pMTL83151) were confirmed to be derived from E. 322 
rectale A1-86 by aerobic growth tests (E. rectale A1-86 does not grow aerobically), Gram-323 
staining, 16S rRNA gene sequencing and SDS PAGE analysis (Fig. 2A). Specific PCR primers 324 
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amplified plasmid sequences only in transconjugants (Fig. 2B, Fig. S2). Transferred plasmids 325 
were shown to be autonomously-replicating rather than chromosomally integrated in E. rectale 326 
A1-86 (Fig. 2C) by Southern blotting. 327 
 328 
Extending the mating protocol to additional strains 329 
The mating protocol was optimised to achieve a transfer frequency of 1.8 x 10-6 330 
transconjugants per potential E. rectale A1-86 recipient. Specifically, increasing the mating 331 
time from 24 h to 48 h increased transfer frequency 10-fold and changing the donor: recipient 332 
ratio from 5:1 to 40:1 increased transfer frequency 5-fold. This optimised protocol was then 333 
used in attempts to conjugate pMTL82151, pMTL83151, pMTL84151 and pMTL85151 into 334 
the range of strictly anaerobic bacterial strains indicated in Table 1. Putative transconjugants 335 
were obtained for transfers of pMTL83151 into E. rectale T1-815 (named ETM3; transfer 336 
frequency of 2.3 x 10-7 per potential recipient), and pMTL82151 and pMTL83151 into R. 337 
inulinivorans A2-194 (transfer frequency of 6.1 x 10-8 (RAM2) and 1.33 x 10-6 (RAM3) per 338 
potential recipient). The identity of these transconjugants was confirmed by Gram-staining, 339 
16S rRNA gene sequencing, testing for aerotolerance and by PCR with primers specific for the 340 
plasmid (Figure S2). The plasmids were shown to be autonomously-replicating by Southern 341 
blotting (Fig. 2C and 2D, Fig. S3), because plasmid DNA extracted from transconjugants co-342 
migrated with purified plasmids from E. coli. 343 
The use of a nitrocellulose filter increased the transfer efficiency of pMTL83151 into 344 
R. inulinivorans A2-194 when a 5:1 donor: recipient ratio was used (5-fold), but did not 345 
improve transfer efficiency when a 40:1 donor: recipient ratio was used. Additionally, mating 346 
on a nitrocellulose filter appeared to completely prevent conjugation of pMTL83151 into E. 347 
rectale T1-815. Thus, nitrocellulose filter mating was not used in the optimised mating 348 
protocol, but rather the donor/recipient cell mixture was spotted directly onto the centre of an 349 
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agar plate. Furthermore, mating on M2GSC and AMM resulted in similar transfer frequencies 350 
(for conjugation of pMTL83151 into E. rectale T1-815 and R. inulinivorans A2-194), meaning 351 
that they could be used interchangeably in the mating protocol. Compared to YCFA, AMM 352 
possesses a lower concentration of acetate (5 mM), a short chain fatty acid that  has been shown 353 
to hinder the growth of E. coli in pure culture [28] and thus might hinder the growth of the E. 354 
coli donor during mating. The optimized mating protocol is shown schematically in Fig. 3. 355 
 356 
Determining plasmid stability of pMTL83151 in E. rectale A1-86 357 
The maintenance of pMTL83151 in E. rectale A1-86 in the absence of chloramphenicol 358 
selection pressure was calculated. Two E. rectale A1-86 transconjugants, EAM3(1) and 359 
EAM3(2 were grown in sequential sub-cultures, re-inoculating every 12 h (~ 8 generations). 360 
The proportion of bacteria still chloramphenicol resistant, and thus still harbouring 361 
pMTL83151, was calculated at each sub-inoculation point and in the final culture after five 362 
sub-inoculations (~40 generations) (Table S2). The first sub-inoculation was excluded from 363 
stability calculations as chloramphenicol was transferred into this culture from the starting 364 
culture during sub-inoculation, whereas chloramphenicol concentrations in subsequent sub-365 
inoculations were deemed too low to select for plasmid persistence. .   366 
The rate of plasmid loss was calculated to be 2% and 5% plasmid loss per generation 367 
in the absence of antibiotic selection for transconjugants EAM3(1) and EAM3(2), respectively. 368 
In practice, this means that for transconjugants grown from lag phase (OD650 0.1) to stationary 369 
phase (OD650 1.0) in a Hungate tube culture (7.5 ml) in the absence of antibiotic selection, over 370 
65 % of the stationary phase bacteria are predicted to retain pMTL83151. 371 
 372 
Heterologous gene expression 373 
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The extracellular β-(1,3-1,4)-glucanase from S. bovis JB1 can be expressed from shuttle 374 
vectors in a diverse range of bacteria (Lactococcus lactis IL2661, Enterococcus faecalis JH2-375 
SS and E. coli DH5α) [29]. This expression, which is readily detected by Congo red staining 376 
of agar plates containing β-glucan, was controlled by the native S. bovis promoter of the β-(1,3-377 
1,4)-glucanase gene and enabled the recipient bacteria to hydrolyse barley β-glucan. Since the 378 
genomes of R. inulinivorans A2-194 and E. rectale T1-815 do not encode a GH16 -(1,3-1,4) 379 
glucanase (29), we chose this enzyme for a proof-of-principle heterologous gene expression 380 
test. 381 
The shuttle plasmid pL1Hc [29] had been constructed by cloning a S. bovis JB1 382 
chromosomal fragment isolated by endonuclease restriction of the genomic DNA into the 383 
plasmid pUC18. pL1Hc therefore contains flanking DNA likely to be non-essential to gene 384 
function, including a putative stress response gene. For a more targeted approach, PCR primers 385 
containing restriction sites were designed to amplify only the β-(1,3-1,4)-glucanase gene and 386 
its regulatory regions from pL1Hc. The resulting amplicon was cloned into pMTL83151, 387 
producing the plasmid pMTL3β-glu (Fig. 4). The purified plasmid was then electroporated into 388 
E. coli strain CA434 and conjugated into R. inulinivorans A2-194 and E. rectale T1-815. 389 
Activity of the heterologously expressed β-(1,3-1,4)-glucanase in the recombinant 390 
strains was assessed by clear zone formation on agar plates overlaid with barley β-(1,3-1,4)-391 
glucan.  In E. coli CA434, the strain lacking pMTL3β-glu produced no clear zones around 392 
single colonies, whereas distinct clear zones were observed around single colonies of the 393 
recombinant strain (Fig. S4). Similarly, for R. inulinivorans A2-194 and E. rectale T1-815, the 394 
wild-type strains produced no clear zones around single colonies, whereas distinct clear zones 395 




 Quantification of β-glucanase activity in the protein extracts by reducing sugar assay 398 
revealed that R. inulinivorans harbouring pMTL3β-glu (RABglu) possessed twice the β-399 
glucanase activity of the wild-type strain A2-194. E. rectale T1-815 harbouring the pMTL3β-400 
glu (ETBglu) possessed over 4-times the β-glucanase activity of the wild-type strain T1-815 401 
(Fig.5b). It is possible that the protein is exported from R. inulinivorans cells more efficiently 402 
than from E. rectale, explaining the activity differences observed in clear zone formation 403 
compared to protein extracts. 404 
 405 
Discussion: 406 
The importance of butyrate-producing bacteria in maintaining intestinal health is now 407 
widely recognised. In recent years, our understanding of the way these bacteria have adapted 408 
to the human intestine by utilising dietary and host derived polysaccharides for energy [30-34] 409 
and by modulating host immunity via flagella [35] has increased. However, a more complete 410 
understanding of the interactions between these bacteria, and with the human host has been 411 
limited by a lack of techniques for gene modification. 412 
The plasmid pMTL83151, which possesses the replication region from pCB102 (from 413 
C. butyricum), was capable of autonomous replication in E. rectale A1-86, E. rectale T1-815 414 
and R. inulinivorans A2-194 while pMTL82151 was capable of replicating in R. inulinivorans 415 
A2-194. The latter plasmid possesses the origin of replication from pBP1, isolated from C. 416 
botulinum. The transfer frequency of this plasmid into R. inulinivorans was 100-1000–fold 417 
lower than that of pMTL83151. However, it appears to have a higher copy number, as a plasmid 418 
was visible by gel electrophoresis of isolated DNA from R. inulinivorans A2-194 possessing 419 
pMTL82151, but not pMTL83151 (data not shown). As all the pMTL80000 series plasmids 420 
were identical apart from the Gram-positive origins of replication, it is likely that our inability 421 
to introduce by conjugation the plasmids pMTL84151 and pMTL85151 into R. inulinivorans 422 
18 
 
A2-194, E. rectale A1-86 and E. rectale T1-815 was due to their inability to replicate in the 423 
recipient cell. It is also possible that recipient restriction enzymes may have inactivated the 424 
plasmid origins of replication.  425 
Expression of the active S. bovis β-glucanase in E. rectale and R. inulinivorans resulted 426 
in activity of the β-glucanase enzyme against β-glucan, although it did not enable the strains to 427 
grow utilising β-glucan as a sole source of energy (data not shown). This suggests that although 428 
the transconjugants were able to degrade β-glucan, these strains are not equipped to import β-429 
glucan or any resulting degradation products and use them for energy. However, -glucanase 430 
expression may offer interesting possibilities in the future as a reporter gene for the analysis of 431 
promoter activity in these bacteria.  432 
In this work, we have taken the first steps towards genetic analysis of the butyrate-433 
producing species Roseburia inulinivorans and Eubacterium rectale which comprise at least 434 
7% of the human intestinal microbiota [36]. The natural progression of this work will involve 435 
using these genetic manipulation tools to interrupt chromosomal genes to establish their 436 
functionality, or introducing new genes conferring novel abilities on the host bacterium. It will 437 
be possible to include different selectable marker genes or alternative origins of replication 438 
from native plasmids within shuttle vectors to expand the use of these genetic manipulation 439 
tools to other related Firmicute bacteria. R. intestinalis L1-82 contains tetracycline resistance 440 
genes conferring resistance to 10µg/ml tetracycline (this work). Introducing this gene onto a 441 
multicopy plasmid would provide an alternative selectable marker. The development of suicide 442 
vectors that cannot themselves replicate in these bacteria, but which contain selectable markers 443 
that can be used to drive homologous recombination and chromosomal integration of 444 
homologous and heterologous genes, or for the insertional inactivation of existing genes, are 445 
crucial to investigating gene function in the mixed ecosystem.  446 
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This work represents a crucial first step towards future studies analysing gene 447 
expression, regulation, function and microbe-host interactions in this important, but little 448 
studied, group of human colonic anaerobic bacteria.  449 
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Table 1. Bacterial strains and plasmids. 459 
Strain/plasmid Relative characteristics Source/Reference 
Strains 
  
Eubacterium rectale A1-86 Butyrate producing, strict anaerobes of the 
Lachnospiraceae family. 
(Barcenilla et al. 2000)  
Eubacterium rectale T1-815 (Barcenilla et al. 2000)  
Eubacterium rectale M104/1 (Louis et al. 2004)  
Eubacterium rectale L2-21 
 
(Barcenilla et al. 2000)  
Roseburia inulinivorans A2-194 
 
(Duncan et al. 2006)  
Roseburia inulinivorans A2-194 RifR 
 
This work 
Roseburia inulinivorans L1-83 
 
(Barcenilla et al. 2000)  
Roseburia faecis M72/1 
 
(Duncan et al. 2006)  
Roseburia intestinalis L1-82 
 
(Duncan et al. 2006)  
Roseburia hominis A2-183 
 
(Duncan et al. 2006) 
  
Eubacterium rectale EAM3 E. rectale A1-86 harbouring pMTL83151 This work 
Eubacterium rectale ETM3 E. rectale T1-815 harbouring pMTL83151 This work 
Eubacterium rectale ETBglu E. rectale T1-815 harbouring pMTL3β-glu This work 
Roseburia inulinivorans RAM2 R. inulinivorans A2-194 harbouring 
pMTL82151 
This work 
Roseburia inulinivorans RAM3 R. inulinivorans A2-194 harbouring 
pMTL83151 
This work 
Roseburia inulinivorans RABglu R. inulinivorans A2-194 harbouring 
pMTL3β-glu 
This work 
   
Faecalibacterium prausnitzii A2-165 Non-motile, butyrate producing, strict 
anaerobes of the Ruminococcaceae family. 
(Duncan et al. 2002)  
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Escherichia coli CA434 Conjugative donor. Genotype: HB101 (thi-
1 hsdS20 (r-B, m-B) supE44 recAB ara-14 
leuB5proA2 lacY1 galK rpsL20 (strR) xyl-5 
mtl-1) carrying R701 (Tra+, Mob+ 
conjugative plasmid) 
(Williams et al. 1990)  
Escherichia coli XL1-Blue Commercial competent cells (Stratagene) 
 
   
Plasmids* 
  
pMTL82151 ColE1, catP, traJ, MCS and pBP1  (Heap et al. 2010b)  
pMTL83151 ColE1, catP, traJ, MCS and pCB102 (Heap et al. 2009)  
pMTL84151 ColE1, catP, traJ, MCS and pCD6 (Heap et al. 2009)  
pMTL85151 ColE1, catP, traJ, MCS and pIM13 (Heap et al. 2009)  
pMTL960 ColE1, catP, traJ, MCS and pCD6;  (Purdy et al. 2002) 
 
Non- modular structure 
 
pMTL3β-glu pMTL83151 modular plasmid with β-(1,3-
1,4)-glucanase gene of Streptococcus bovis 
JB1 expressed from multiple cloning site. 
This work 
*pBP1, pCB102, pCD6 and pIM13 (replicons of these plasmids). ColE1 (Gram-negative 460 
replicon), catP (chloramphenicol resistance gene), traJ (origin of transfer) and MCS (multiple 461 
cloning site). A2-194 RifR was created by selecting spontaneous mutations that conferred 462 
rifampicin resistance to A2-194. Overnight cultures were streaked on plates containing 463 
100µg/ml rifampicin and incubated anaerobically at 37 °C for 120 h. Single colonies were 464 
subsequently purified and the resistance levels checked. 465 
 466 
Table 2. Antibiotic sensitivity testing of strains studied. 467 
Species Strain Cm5 Tm5 Erm10 Erm25 Tet10 Tet25 Rif10 Rif25 
E. rectale A1-86 - - - - - - - - 
 
M104/1 - - - - - - - - 
 
T1-815 - - - - - - - - 
 
L2-21 - - - - - - - - 
R. inulinivorans A2-194 - - + + - - - - 
 
A2-194 RifR* - - + + - - + + 
 
L1-83 - - - - - - - - 
R. hominis A2-183 - - - - - - - - 
R. faecis M72/1 - - - - - - - - 
R. intestinalis L1-82 - - - - + - - - 
F. prausnitzii A2-165 - - - - - - - - 
Growth of colonies (+) and no growth (-) on YCFAGSC plates supplemented 468 
with antibiotic at levels indicated. Chloramphenicol (Cm), thiamphenicol (Tm), 469 
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erythromycin (Erm), tetracycline (Tet) and rifampicin (Rif). 5, 10 and 25 470 
indicate 5 μg/ml, 10 μg/ml and 25 μg/ml, respectively.  471 
 472 
Table 3. Growth data for strains and media tested for mating and selection of 473 





M2 Y M2 AMM Y Y(0.25)FA AMMcm5 Ycm5 
E. rectale A1-86 - - + + + + + - 
 
M104/1 - - + + + + + - 
 
T1-815 - - + + + + + - 
 
L2-21 - - + + + + + - 
R. inulinivorans A2-194 - - + + + + + - 
 
L1-83 - - + + + + - - 
R. faecis M72/1 - - + + + + - - 
R. intestinalis L1-82 - - + + + + - - 
R. hominis A2-183 - - + + + + + - 
F. prausnitzii A2-165 - - + + + + + - 
E. coli  CA434 + + + + - + + - 
Growth of colonies (+) and no growth (-). Anaerobic mating medium (AMM), YCFAGSC (Y), 475 
M2GSC (M2), YCFAGSC with only one quarter of the normal concentration of each short-476 
chain fatty acid (Y(0.25)FA). 5 μg/ml of chloramphenicol (cm5). 477 
 478 
Table 4. Summary of in silico prediction of restriction-modification systems. 479 
Strain Restriction-modification systems 
E. rectale A1-86 
R. inulinivorans A2-194 
R. intestinalis L1-82 
F. prausnitzii A2-165 
1 Type I, 2 Type II 
1 Type I 
1 Type I, 1 Type II 
4 Type I, 2 Type II, 1 Type III 






Figure 1. Restriction profile of plasmid DNA incubated with protein extracts. Protein 484 
extracts from: A (Eubacterium rectale A1-86), B (Faecalibacterium prausnitzii A2-165), C 485 
(Roseburia faecis M72/1), D (Roseburia intestinalis L1-82), E (Roseburia inulinivorans A2-486 
194) and + (no protein extract) were incubated with each of the four plasmids shown at 37 °C 487 
for 90 minutes. The restriction enzyme buffer used for each extract was the one shown to 488 
generate the clearest restriction bands by λ DNA restriction. The size reference used (left hand 489 
lane) was the Promega 1 Kb DNA ladder. 490 
 491 
Figure 2. Verification of transconjugants. A. Coomassie staining of cell lysates reveals that 492 
transconjugants (EAM3, 1 and 2) have the same SDS protein profile as E. rectale A1-86, 493 
different to lane 1 containing the E. coli donor. B. PCR screening for plasmid reveals its 494 
presence in the transconjugants and not in wild-type A1-86 recipient (The complete PCR gel 495 
image is shown in Fig. S2). C, D. Southern blotting of plasmids shows that they have not 496 
inserted into the recipient chromosome in: C. Eubacterium rectale A1-86 harbouring 497 
pMTL83151 (EAM3), E. rectale T1-815 harbouring pMTL83151 (ETM3) and Roseburia 498 
inulinivorans A2-194 harbouring pMTL83151 (RAM3) or in D. Roseburia inulinivorans A2-499 
194 harbouring pMTL82151 (RAM2). 500 
Figure 3. Diagrammatic representation of the optimised conjugation protocol. 501 
Chloramphenicol (Cm). Media as described in Table 3 and Materials and Methods section. 502 
 503 
Figure 4. Construction of the pMTL3β-glu expression vector. The β-(1,3-1,4)-glucanase 504 
gene from S. bovis JB1 was amplified from pL1Hc using primers possessing 5’-end restriction 505 
sites for BamHI and HindIII. This restriction-flanked amplicon and pMTL83151 were 506 
restricted with BamHI and HindIII in separate reactions, purified and ligated together with T4 507 
ligase. Dashed lines in pL1Hc indicate where the cloned fragment attaches to the multiple 508 
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cloning site of the pUC18 backbone. repH is the replicon of pBP1 (replication in Gram-positive 509 
bacteria), catP is the chloramphenicol resistance gene, ColE1 RNAII is the replicon of ColE1 510 
(replication  in Gram-negative bacteria) and traJ is the origin of transfer. 511 
 512 
Figure 5. β-(1,3-1,4)-glucanase activity A) Activity plates show barley β-glucan degradation 513 
after overnight anaerobic incubation with wild-type R. inulinivorans A2-194 and E. rectale T1-514 
815 or pMTL3β-glu-harbouring transconjugants. Clear zones surrounding bacterial colonies 515 
illustrate areas in which the barley β-glucan has been hydrolysed. Transconjugant codes are: 516 
Eubacterium rectale T1-815 harbouring pMTL3β-glu (ETBglu) and Roseburia inulinivorans 517 
A2-194 harbouring pMTL3β-glu (RABglu). B) Barley β-glucan degradation after two hour 518 
aerobic incubation of 1% Glucagel with sonicated extracts from Roseburia inulinivorans A2-519 
194 or R. inulinivorans RABglu and Eubacterium rectale T1-815 or E. rectale ETBglu. Bars 520 




[1] F. Van Immerseel, R. Ducatelle, M. De Vos, N. Boon, T. Van De Wiele, K. Verbeke, P. 525 
Rutgeerts, B. Sas, P. Louis, H.J. Flint, Butyric acid-producing anaerobic bacteria as a novel 526 
probiotic treatment approach for inflammatory bowel disease, J. Med. Microbiol. 59 (2010) 527 
141-143. 528 
[2] J. Durack, S.V. Lynch, The gut microbiome: Relationships with disease and opportunities 529 
for therapy, J. Exp. Med. 216 (2019) 20-40. 530 
[3] L. Peng, Z.R. Li, R.S. Green, I.R. Holzman, J. Lin, Butyrate enhances the intestinal 531 
barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase 532 
in Caco-2 cell monolayers, J. Nutr. 139 (2009) 1619-1625. 533 
[4] J. Schauber, R.A. Dorschner, K. Yamasaki, B. Brouha, R.L. Gallo, Control of the innate 534 
epithelial antimicrobial response is cell-type specific and dependent on relevant 535 
microenvironmental stimuli, Immunology. 118 (2006) 509-519. 536 
24 
 
[5] I.A. Finnie, A.D. Dwarakanath, B.A. Taylor, J.M. Rhodes, Colonic mucin synthesis is 537 
increased by sodium butyrate, Gut. 36 (1995) 93-99. 538 
[6] A.L. Millard, P.M. Mertes, D. Ittelet, F. Villard, P. Jeannesson, J. Bernard, Butyrate 539 
affects differentiation, maturation and function of human monocyte-derived dendritic cells 540 
and macrophages, Clin. Exp. Immunol. 130 (2002) 245-255. 541 
[7] P.V. Chang, L. Hao, S. Offermanns, R. Medzhitov, The microbial metabolite butyrate 542 
regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. 543 
Sci. U. S. A. 111 (2014) 2247-2252. 544 
[8] J.H. Cho, C. Abraham, Inflammatory bowel disease genetics: Nod2, Annu. Rev. Med. 58 545 
(2007) 401-416. 546 
[9] A. Barcenilla, S.E. Pryde, J.C. Martin, S.H. Duncan, C.S. Stewart, C. Henderson, H.J. 547 
Flint, Phylogenetic relationships of butyrate-producing bacteria from the human gut, Appl. 548 
Environ. Microbiol. 66 (2000) 1654-1661. 549 
[10] K. Terpe, Overview of bacterial expression systems for heterologous protein production: 550 
from molecular and biochemical fundamentals to commercial systems, Appl. Microbiol. 551 
Biotechnol. 72 (2006) 211-222. 552 
[11] F. Bernaudat, A. Frelet-Barrand, N. Pochon, S. Dementin, P. Hivin, S. Boutigny, J. 553 
Rioux, D. Salvi, D. Seigneurin-Berny, P. Richaud, Heterologous expression of membrane 554 
proteins: choosing the appropriate host, PloS one. 6 (2011) e29191. 555 
[12] E.D. Carlson, R. Gan, C.E. Hodgman, M.C. Jewett, Cell-free protein synthesis: 556 
applications come of age, Biotechnol. Adv. 30 (2012) 1185-1194. 557 
[13] B. Miroux, J.E. Walker, Over-production of Proteins in Escherichia coli: Mutant Hosts 558 
that Allow Synthesis of some Membrane Proteins and Globular Proteins at High Levels, J. 559 
Mol. Biol. 260 (1996) 289-298. 560 
[14] M.A. Fischbach, Microbiome: focus on causation and mechanism, Cell. 174 (2018) 785-561 
790. 562 
[15] K.P. Scott, J.C. Martin, J. Mrazek, H.J. Flint, Transfer of conjugative elements from 563 
rumen and human Firmicutes bacteria to Roseburia inulinivorans, Appl. Environ. Microbiol. 564 
74 (2008) 3915-3917. 565 
[16] J.T. Heap, O.J. Pennington, S.T. Cartman, N.P. Minton, A modular system for 566 
Clostridium shuttle plasmids, J. Microbiol. Methods. 78 (2009) 79-85. 567 
[17] K. Miyazaki, J.C. Martin, R. Marinsek-Logar, H.J. Flint, Degradation and utilization of 568 
xylans by the rumen anaerobe Prevotella bryantii (formerly P. ruminicola subsp. brevis) 569 
B(1)4, Anaerobe. 3 (1997) 373-381. 570 
[18] M. Lopez-Siles, T.M. Khan, S.H. Duncan, H.J. Harmsen, L.J. Garcia-Gil, H.J. Flint, 571 
Cultured representatives of two major phylogroups of human colonic Faecalibacterium 572 
25 
 
prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth, Appl. 573 
Environ. Microbiol. 78 (2012) 420-428. 574 
[19] M. Bryant, Commentary on the Hungate technique for culture of anaerobic bacteria, Am. 575 
J. Clin. Nutr. 25 (1972) 1324-1328. 576 
[20] K. Rutherford, J. Parkhill, J. Crook, T. Horsnell, P. Rice, M.A. Rajandream, B. Barrell, 577 
Artemis: sequence visualization and annotation, Bioinformatics. 16 (2000) 944-945. 578 
[21] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning, Cold spring harbor laboratory 579 
press New York, 1989. 580 
[22] K.P. Scott, H. Flint, Transfer of plasmids between strains of Escherichia coli under 581 
rumen conditions, J. Appl. Bacteriol. 78 (1995) 189-193. 582 
[23] D. Purdy, T.A. O'Keeffe, M. Elmore, M. Herbert, A. McLeod, M. Bokori-Brown, A. 583 
Ostrowski, N.P. Minton, Conjugative transfer of clostridial shuttle vectors from Escherichia 584 
coli to Clostridium difficile through circumvention of the restriction barrier, Mol. Microbiol. 585 
46 (2002) 439-452. 586 
[24] M. Lever, Carbohydrate determination with 4-hydroxybenzoic acid hydrazide 587 
(PAHBAH): effect of bismuth on the reaction, Anal. Biochem. 81 (1977) 21-27. 588 
[25] H.J. Flint, C.A. McPherson, J. Martin, Expression of two xylanase genes from the rumen 589 
cellulolytic bacterium Ruminococcus flavefaciens 17 cloned in pUC13, J. Gen. Microbiol. 590 
137 (1991) 123-129. 591 
[26] K.A. Kazimierczak, M.T. Rincon, A.J. Patterson, J.C. Martin, P. Young, H.J. Flint, K.P. 592 
Scott, A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a 593 
human gut firmicute bacterium and in metagenomic library clones, Antimicrob. Agents 594 
Chemother. 52 (2008) 4001-4009. 595 
[27] H. Flint, A. Thomson, Deoxyribonuclease activity in rumen bacteria, Lett. Appl. 596 
Microbiol. 11 (1990) 18-21. 597 
[28] A.J. Roe, C. O'Byrne, D. McLaggan, I.R. Booth, Inhibition of Escherichia coli growth 598 
by acetic acid: a problem with methionine biosynthesis and homocysteine toxicity, 599 
Microbiology. 148 (2002) 2215-2222. 600 
[29] M.S. Ekinci, S.I. McCrae, H.J. Flint, Isolation and overexpression of a gene encoding an 601 
extracellular beta-(1,3-1,4)-glucanase from Streptococcus bovis JB1, Appl. Environ. 602 
Microbiol. 63 (1997) 3752-3756. 603 
[30] K.P. Scott, J.C. Martin, C. Chassard, M. Clerget, J. Potrykus, G. Campbell, C.D. Mayer, 604 
P. Young, G. Rucklidge, A.G. Ramsay, H.J. Flint, Substrate-driven gene expression in 605 
Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and 606 
starch, Proc. Natl. Acad. Sci. U. S. A. 108 Suppl 1 (2011) 4672-4679. 607 
26 
 
[31] K.P. Scott, J.C. Martin, G. Campbell, C.D. Mayer, H.J. Flint, Whole-genome 608 
transcription profiling reveals genes up-regulated by growth on fucose in the human gut 609 
bacterium "Roseburia inulinivorans", J. Bacteriol. 188 (2006) 4340-4349. 610 
[32] D.W. Cockburn, N.I. Orlovsky, M.H. Foley, K.J. Kwiatkowski, C.M. Bahr, M. 611 
Maynard, B. Demeler, N.M. Koropatkin, Molecular details of a starch utilization pathway in 612 
the human gut symbiont Eubacterium rectale, Mol. Microbiol. (2015). 613 
[33] A.G. Ramsay, K.P. Scott, J.C. Martin, M.T. Rincon, H.J. Flint, Cell-associated alpha-614 
amylases of butyrate-producing Firmicute bacteria from the human colon, Microbiology. 152 615 
(2006) 3281-3290. 616 
[34] P.O. Sheridan, J.C. Martin, T.D. Lawley, H.P. Browne, H.M. Harris, A. Bernalier-617 
Donadille, S.H. Duncan, P.W. O'Toole, K.P. Scott, H.J. Flint, Polysaccharide utilisation loci 618 
and nutritional specialisation in a dominant group of butyrate-producing human colonic 619 
Firmicutes., Microbial Genomics (2015). 620 
[35] B.A. Neville, P.O. Sheridan, H.M. Harris, S. Coughlan, H.J. Flint, S.H. Duncan, I.B. 621 
Jeffery, M.J. Claesson, R.P. Ross, K.P. Scott, Pro-inflammatory flagellin proteins of 622 
prevalent motile commensal bacteria are variably abundant in the intestinal microbiome of 623 
elderly humans, PloS one. 8 (2013) e68919. 624 
[36] A. Zhernakova, A. Kurilshikov, M.J. Bonder, E.F. Tigchelaar, M. Schirmer, T. Vatanen, 625 
Z. Mujagic, A.V. Vila, G. Falony, S. Vieira-Silva, J. Wang, F. Imhann, E. Brandsma, S.A. 626 
Jankipersadsing, M. Joossens, M.C. Cenit, P. Deelen, M.A. Swertz, LifeLines cohort study, 627 
R.K. Weersma, E.J. Feskens, M.G. Netea, D. Gevers, D. Jonkers, L. Franke, Y.S. Aulchenko, 628 
C. Huttenhower, J. Raes, M.H. Hofker, R.J. Xavier, C. Wijmenga, J. Fu, Population-based 629 
metagenomics analysis reveals markers for gut microbiome composition and diversity, 630 
Science. 352 (2016) 565-569. 631 
  632 
Table S1. Oligonucleotide primers. 
Primer Sequence (5'-3') Target Reference 
PS#MTL-for TATCTATGATACCGTGGTCAAC pMTL80000 series plasmids  This work 
PS#MTL-rev CTGCTGAAGCCAGTTACC pMTL80000 series plasmids  This work  
PS#Bglu-
BamHI-for 
GGCCGGATCCGATATTGGCTGCAGTTATT S. bovis JB1 β-glucanase 







FD1 AGAGTTTGATCCTGGCTCAG Full 16S rRNA gene [1]  
RP2 ACGGCTACCTTGTTACGACTT Full 16S rRNA gene [1]  
519R GWATTACCGCGGCKGCTG 16S rRNA gene (universal) [2] 
926F ACTCAAAGGAATTGACGG 16S rRNA gene (universal) [3] 




Table S2. Stability of pMTL83151 in E. rectale A1-86 in the absence of antibiotic selection. 










1 0.92 0.96 8 - - 
2 0.88 0.50 16 0.01 0.05 
3 0.74 0.21 24 0.01 0.06 
4 0.60 0.18 32 0.02 0.05 
5 0.44 0 40 0.02 -    
Average 0.02 0.05 
E. rectale A1-86 transconjugants EAM3(1) and EAM3(2), harbouring pMTL83151, were isolated from independent 
conjugations. Number of generations was estimated by incubation time. Stability was calculated using the equation x 
= 1 – R1/N, where x = segregational instability and was taken as the average of sub-inoculums 2-5 for EAM3(1) and 2-










 Table S3. Detailed in silico prediction of restriction-modification systems.  
Strain 
 
Locus tag Annotation 
R. intestinalis L1-82 Type I RINT_03062c Type 1 RM system, R subunit 
  
RINT_03061c Type 1 RM system, M subunit 
  
RINT_03060c Type 1 RM system, S subunit 
 
Type II RINT_00004c BspRI-like methylase 
  
RINT_00005c BspRI-like restriction endonuclease 
  
RINT_00287c Eco57I-like methylase 
  
RINT_00286c BsuBI/PstI-like restriction endonuclease 
R. inulinivorans A2-194 Type I RINU_01867c R subunit 
  
RINU_01866c M subunit 
  
RINU_01864c S subunit 
E. rectale A1-86 Type I EUR_27160 M subunit 
  
EUR_27170 S subunit 
  
EUR_27190 nucleotidyltransferase substrate binding protein 
  
EUR_27200 Site-specific recombinase XerD 
  
EUR_27210 S subunit 
  
EUR_27220 Predicted AAA-ATPase 
  
EUR_27230 R subunit 
 
Type II EUR_02430 DNA adenine methylase (dam) 
  
EUR_02440 Hypothetical protein 
  
EUR_02450 DpnIIB-like methylase 
  
EUR_02460 5-methylcytosine-specific restriction enzyme 
  
EUR_02470 DpnII-like restriction endonuclease 
  
EUR_07860 D12 class N6 adenine-specific DNA methylase 
  
EUR_07870 MjaII-like restriction endonuclease 
F. prausnitzii A2-165 Type I FPRAU_01424 Type 1 RM system, DNA inversion 
  
FPRAU_00430c Type 1 RM system, DNA inversion 
  
FPRAU_02637c Type 1 RM system, looks like DNA inversion but 
no inverted repeats   
FPRAU_03233 Type 1 RM system 
 
Type II FPRAU_00871 Eco57I-like methylase 
  
FPRAU_00872 Restriction endonuclease 
  
FPRAU_01759 NgoMIV-like methylase 
  
FPRAU_01758 NgoMIV-like restriction endonuclease 
 
Type III FPRAU_00185c Hypothetical protein 
  
FPRAU_00184c M subunit 
  
FPRAU_00183c R subunit 
  
FPRAU_00182c Hypothetical protein 
  
FPRAU_00181c TIR-domain containing protein 









Figure S2. Original gel electrophoresis images of PCR verification of transconjugants. 
This original gel image contains some negative results that have been labelled #. 
The confirmed transconjugants are labelled as described in the main manuscript. The size 
reference used (left hand lane) was the Promega 1 Kb DNA ladder. The positive control (+) is 
the plasmid pMTL82151, which is identical to the pMTL83151 in the amplified region. 
 
  
Figure S3. Original southern blot images at 10 mins and 40 mins film exposure. 
 
 
Figure S4. Beta-glucanase activity by conjugation donor E. coli CA434 harbouring 
pMTL3β-glu. Barley β-glucan degradation after overnight aerobic incubation with wild-type 
or pMTL3β-glu-harbouring transformants of conjugation donor E. coli CA434. Clear zones 
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